Notably, TLR dysregulation in MDS and AML is associated with poor prognosis and genomic instability, whereas in CML, TLRs contribute to a protective microenvironment via NOD‐like and TNF‐α pathways. This evidence concerns the gene TNF and chronic myelogenous leukemia, BCR-ABL1 positive.